Search

Your search keyword '"Lalani, Tahaniyat"' showing total 481 results

Search Constraints

Start Over You searched for: Author "Lalani, Tahaniyat" Remove constraint Author: "Lalani, Tahaniyat"
481 results on '"Lalani, Tahaniyat"'

Search Results

1. Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines

2. Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

3. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

4. Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

5. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

6. Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci

7. Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19

8. Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States

9. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

10. Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism Risk.

11. SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-up

15. Gut microbiome and antibiotic resistance effects during travelers’ diarrhea treatment and prevention

16. Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States

18. Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

20. 387. Understanding the Impact of COVID-19 on Cognitive Function Using a Scalable, App-based, Self-administered Tool in the Military

21. 441. Prior SARS-CoV-2 Diagnosis is a Risk Factor for Herpes Zoster in Younger Adults: A Nested Case-control Study in the EPICC Cohort

22. 1573. Viral Blips While on Antiretroviral Therapy are Associated with Virologic Failure

23. 437. Does “Long COVID” Resolve by One Year in U.S. Military Health System Beneficiaries?

24. 1352. A Precision Medicine Approach to Predicting “Long COVID” through Machine Learning Analysis of Whole Blood Transcriptome Data

26. Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

28. Low Level Viremia Is Associated With Serious non-AIDS Events in People With HIV.

30. Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort Study.

31. Age-associated variations in anti-spike antibody responses in mild SARS-CoV-2 disease.

32. 273. Emergence of the SARS-CoV-2 Omicron Variant in the Pragmatic Assessment of Influenza Vaccine Effectiveness in the Department of Defense (PAIVED) Study

34. 1102. The Host Response to SARS-CoV-2 Infection Differs by Age

35. 2200. Impact of COVID-19 Pandemic on Influenza-like Illness (ILI) Experience among Healthcare Workers in Military Treatment Facilities

36. 1066. Precision phenotyping of “long COVID” through machine learning

37. 80. SARS-CoV-2 infection is associated with decreased reported physical fitness in a US military longitudinal cohort

38. 2206. Pragmatic Assessment of Influenza Vaccine Effectiveness in the Department of Defense (PAIVED): Updates from Year 4 of a Multi-site Trial

39. 2204. Pathogen Co-infections and Trends in Influenza-like Illness in PAIVED

41. 5 Rifaximin prophylaxis against travellers’ diarrhoea does nor increase acquisition of extended-spectrum ß – lactamase producing enterobacteriaceae (ESBL-E) in a UK military population travelling to Kenya

42. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

44. Post-vaccination Omicron infections induce broader immunity across antigenic space than prototype mRNA COVID-19 booster vaccination or primary infection

46. Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

48. SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies

Catalog

Books, media, physical & digital resources